UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Decreased by Overbrook Management Corp

Overbrook Management Corp trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 29.2% in the 1st quarter, Holdings Channel reports. The firm owned 32,132 shares of the healthcare conglomerate’s stock after selling 13,245 shares during the quarter. UnitedHealth Group accounts for 4.3% of Overbrook Management Corp’s holdings, making the stock its 9th biggest holding. Overbrook Management Corp’s holdings in UnitedHealth Group were worth $15,896,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in the stock. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $26,000. CGC Financial Services LLC raised its position in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth $31,000. LFA Lugano Financial Advisors SA lifted its stake in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the period. Finally, Transcendent Capital Group LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 2.6 %

Shares of UnitedHealth Group stock opened at $499.25 on Friday. The firm has a fifty day moving average price of $498.30 and a 200 day moving average price of $502.61. The stock has a market cap of $459.50 billion, a PE ratio of 29.74, a price-to-earnings-growth ratio of 1.40 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.26 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a dividend of $2.10 per share. The ex-dividend date was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.68%. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Analyst Ratings Changes

UNH has been the topic of several research reports. Truist Financial reissued a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Robert W. Baird assumed coverage on UnitedHealth Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $597.00 target price on the stock. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Finally, JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.